# FDA Inspection 1277212 - RedPharm Drug - August 01, 2025

Source: https://www.keypedia.com/records/fda_inspections/redpharm-drug/e00d068f-93e8-4290-9b3b-d7e6a5f46c3c
Source feed: FDA_Inspections

> FDA Inspection 1277212 for RedPharm Drug on August 01, 2025. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1277212
- Company Name: RedPharm Drug
- Inspection Date: 2025-08-01
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Office Name: Minneapolis District Office

## Related Documents

- [FDA Inspection 1030658 - 2017-11-03](https://www.keypedia.com/records/fda_inspections/redpharm-drug/a0e67f75-cfe4-467a-9b1a-eeb4b0d2a23e)
- [FDA Inspection 848068 - 2013-09-11](https://www.keypedia.com/records/fda_inspections/redpharm-drug/897c3293-396b-4601-a12f-b5691c422fc4)
- [FDA Inspection 636090 - 2009-12-29](https://www.keypedia.com/records/fda_inspections/redpharm-drug/a5a7d46e-65ae-4872-8298-3f9e4117b006)

Company: https://www.keypedia.com/companies/redpharm-drug/0d1a0e3e-dfbe-4e3a-b4fd-04ede1b1252e

Office: https://www.keypedia.com/offices/minneapolis-district-office/c79fc8dc-f884-48fc-ba80-2947f662511d